In both the high-risk and low-risk groups, the graft survival and rejection-free graft survival rates were not affected by the H-Y compatibility. The graft survival (p < 0.001) and rejection-free graft survival (p < 0.001) rates were higher in the low-risk group than in the high-risk group. High-risk PKP was associated with greater risk of graft failure (risk ratio, 2.33) and rejection (risk ratio, 2.05) than low-risk PKP. Conclusion H-Y antigen matching does not influence the rate of allograft rejection after PKP.
The pre-operative diagnoses are shown in Table 1 . (1 mg/ml), ofloxacin and tropicamide were prescribed as post-operative treatment. Topical treatment was tapered off over several months: from 6 times a day post operatively to 4 times a day at 3 months, 3 times daily at 6 months, and twice daily at 12 months. The corneal sutures were usually removed 12-18 months after surgery.
HY-compatible HY -incompatible Overall
High-risk transplants (n = 168) 
Results
In the high-risk group, graft survival ( risk of graft failure (risk ratio, 2.33; p < 0.0001) and rejection (risk ratio, 2.05; p = 0.0006) than low-risk PKP ( Table 2) .
Discussion
In humans, the overall number and complexity of minor � 0.9 .... .. 0.6
:'" · �' · t . Follow up (months) Volker-Dieben et a/.30 found that a female donor cornea afforded significantly better graft survival at 1 year in female (85%) than in male (76%) recipients.
A male donor did not affect graft survival in male recipients (79%) compared with female recipients (80%).
They did not mention the mechanism and reason for their results, and we also have no clear explanation of their data. In the current study, the combination of male donor-male recipient did not improve the graft survival rate compared with the male donor-female recipient combination, Moreover, the female donor-male recipient combination did not offer better graft survival rate than the female donor-female recipient combination. We could not find any influences of sex differences between the donors and recipients.
We did not match HLA antigens between donors and recipients. The grafts were all allocated randomly regardless of HLA antigens and sex. The matching of HLA antigens would be effective in preventing allograft rejection after PKP, especially in high-risk patients, but it is very difficult to find a donor and recipient whose HLA antigens match, because the HLA antigens of donors are not usually examined in Japan. However, it could be argued that H-Y incompatibility is only likely to be 
